nodes	percent_of_prediction	percent_of_DWPC	metapath
Ponatinib—CYP2D6—Alzheimer's disease	0.204	1	CbGaD
Ponatinib—CYP2D6—Rivastigmine—Alzheimer's disease	0.066	0.264	CbGbCtD
Ponatinib—CYP2D6—Donepezil—Alzheimer's disease	0.0527	0.211	CbGbCtD
Ponatinib—CYP3A4—Rivastigmine—Alzheimer's disease	0.042	0.168	CbGbCtD
Ponatinib—CYP2D6—Galantamine—Alzheimer's disease	0.034	0.136	CbGbCtD
Ponatinib—CYP3A4—Donepezil—Alzheimer's disease	0.0335	0.134	CbGbCtD
Ponatinib—CYP3A4—Galantamine—Alzheimer's disease	0.0216	0.0865	CbGbCtD
Ponatinib—FGFR4—embryo—Alzheimer's disease	0.00398	0.0395	CbGeAlD
Ponatinib—Nilotinib—MAPK8—Alzheimer's disease	0.00324	0.518	CrCbGaD
Ponatinib—TEK—blood vessel—Alzheimer's disease	0.00286	0.0284	CbGeAlD
Ponatinib—FGFR3—embryo—Alzheimer's disease	0.00272	0.027	CbGeAlD
Ponatinib—SRC—blood vessel—Alzheimer's disease	0.00254	0.0252	CbGeAlD
Ponatinib—FGFR3—forebrain—Alzheimer's disease	0.0024	0.0239	CbGeAlD
Ponatinib—KDR—blood vessel—Alzheimer's disease	0.00234	0.0232	CbGeAlD
Ponatinib—FGFR3—telencephalon—Alzheimer's disease	0.00221	0.0219	CbGeAlD
Ponatinib—BCR—forebrain—Alzheimer's disease	0.00208	0.0206	CbGeAlD
Ponatinib—KIT—blood vessel—Alzheimer's disease	0.00207	0.0206	CbGeAlD
Ponatinib—BCR—telencephalon—Alzheimer's disease	0.00191	0.019	CbGeAlD
Ponatinib—FGFR4—nervous system—Alzheimer's disease	0.00191	0.019	CbGeAlD
Ponatinib—RET—embryo—Alzheimer's disease	0.00187	0.0186	CbGeAlD
Ponatinib—FGFR4—central nervous system—Alzheimer's disease	0.00184	0.0183	CbGeAlD
Ponatinib—FGFR4—cerebellum—Alzheimer's disease	0.0018	0.0179	CbGeAlD
Ponatinib—FGFR2—embryo—Alzheimer's disease	0.00178	0.0177	CbGeAlD
Ponatinib—Nilotinib—CA4—Alzheimer's disease	0.00171	0.274	CrCbGaD
Ponatinib—TEK—embryo—Alzheimer's disease	0.00171	0.0169	CbGeAlD
Ponatinib—FGFR1—telencephalon—Alzheimer's disease	0.0017	0.0169	CbGeAlD
Ponatinib—FGFR2—forebrain—Alzheimer's disease	0.00157	0.0156	CbGeAlD
Ponatinib—PDGFRA—embryo—Alzheimer's disease	0.00154	0.0153	CbGeAlD
Ponatinib—SRC—embryo—Alzheimer's disease	0.00151	0.015	CbGeAlD
Ponatinib—FGFR4—brain—Alzheimer's disease	0.00146	0.0145	CbGeAlD
Ponatinib—FGFR2—telencephalon—Alzheimer's disease	0.00145	0.0144	CbGeAlD
Ponatinib—KDR—embryo—Alzheimer's disease	0.00139	0.0138	CbGeAlD
Ponatinib—TEK—telencephalon—Alzheimer's disease	0.00139	0.0138	CbGeAlD
Ponatinib—PDGFRA—forebrain—Alzheimer's disease	0.00137	0.0136	CbGeAlD
Ponatinib—SRC—forebrain—Alzheimer's disease	0.00134	0.0133	CbGeAlD
Ponatinib—LYN—nervous system—Alzheimer's disease	0.00131	0.013	CbGeAlD
Ponatinib—FGFR3—nervous system—Alzheimer's disease	0.0013	0.013	CbGeAlD
Ponatinib—LYN—central nervous system—Alzheimer's disease	0.00126	0.0125	CbGeAlD
Ponatinib—PDGFRA—telencephalon—Alzheimer's disease	0.00126	0.0125	CbGeAlD
Ponatinib—FGFR3—central nervous system—Alzheimer's disease	0.00126	0.0125	CbGeAlD
Ponatinib—KIT—embryo—Alzheimer's disease	0.00123	0.0123	CbGeAlD
Ponatinib—KDR—forebrain—Alzheimer's disease	0.00123	0.0122	CbGeAlD
Ponatinib—SRC—telencephalon—Alzheimer's disease	0.00123	0.0122	CbGeAlD
Ponatinib—FGFR3—cerebellum—Alzheimer's disease	0.00123	0.0122	CbGeAlD
Ponatinib—BCR—nervous system—Alzheimer's disease	0.00113	0.0112	CbGeAlD
Ponatinib—BCR—central nervous system—Alzheimer's disease	0.00109	0.0108	CbGeAlD
Ponatinib—ABL1—embryo—Alzheimer's disease	0.00108	0.0107	CbGeAlD
Ponatinib—BCR—cerebellum—Alzheimer's disease	0.00106	0.0105	CbGeAlD
Ponatinib—FLT3—cerebellum—Alzheimer's disease	0.00105	0.0105	CbGeAlD
Ponatinib—KIT—telencephalon—Alzheimer's disease	0.001	0.00997	CbGeAlD
Ponatinib—LYN—brain—Alzheimer's disease	0.001	0.00995	CbGeAlD
Ponatinib—FGFR3—brain—Alzheimer's disease	0.000997	0.0099	CbGeAlD
Ponatinib—FGFR1—cerebellum—Alzheimer's disease	0.000945	0.00938	CbGeAlD
Ponatinib—RET—nervous system—Alzheimer's disease	0.000899	0.00892	CbGeAlD
Ponatinib—ABL1—telencephalon—Alzheimer's disease	0.000874	0.00868	CbGeAlD
Ponatinib—RET—central nervous system—Alzheimer's disease	0.000865	0.00859	CbGeAlD
Ponatinib—BCR—brain—Alzheimer's disease	0.000863	0.00857	CbGeAlD
Ponatinib—FGFR2—nervous system—Alzheimer's disease	0.000854	0.00848	CbGeAlD
Ponatinib—RET—cerebellum—Alzheimer's disease	0.000846	0.0084	CbGeAlD
Ponatinib—FGFR2—central nervous system—Alzheimer's disease	0.000822	0.00816	CbGeAlD
Ponatinib—TEK—nervous system—Alzheimer's disease	0.000819	0.00813	CbGeAlD
Ponatinib—FGFR2—cerebellum—Alzheimer's disease	0.000804	0.00798	CbGeAlD
Ponatinib—TEK—central nervous system—Alzheimer's disease	0.000788	0.00783	CbGeAlD
Ponatinib—TEK—cerebellum—Alzheimer's disease	0.00077	0.00765	CbGeAlD
Ponatinib—FGFR1—brain—Alzheimer's disease	0.000768	0.00762	CbGeAlD
Ponatinib—PDGFRA—nervous system—Alzheimer's disease	0.000742	0.00736	CbGeAlD
Ponatinib—SRC—nervous system—Alzheimer's disease	0.000727	0.00722	CbGeAlD
Ponatinib—PDGFRA—central nervous system—Alzheimer's disease	0.000714	0.00709	CbGeAlD
Ponatinib—SRC—central nervous system—Alzheimer's disease	0.0007	0.00695	CbGeAlD
Ponatinib—PDGFRA—cerebellum—Alzheimer's disease	0.000698	0.00693	CbGeAlD
Ponatinib—RET—brain—Alzheimer's disease	0.000687	0.00682	CbGeAlD
Ponatinib—SRC—cerebellum—Alzheimer's disease	0.000684	0.0068	CbGeAlD
Ponatinib—KDR—nervous system—Alzheimer's disease	0.000669	0.00664	CbGeAlD
Ponatinib—FGFR2—brain—Alzheimer's disease	0.000653	0.00648	CbGeAlD
Ponatinib—KDR—central nervous system—Alzheimer's disease	0.000644	0.0064	CbGeAlD
Ponatinib—KDR—cerebellum—Alzheimer's disease	0.00063	0.00625	CbGeAlD
Ponatinib—TEK—brain—Alzheimer's disease	0.000626	0.00621	CbGeAlD
Ponatinib—KIT—nervous system—Alzheimer's disease	0.000593	0.00589	CbGeAlD
Ponatinib—Dehydration—Memantine—Alzheimer's disease	0.000578	0.00274	CcSEcCtD
Ponatinib—Angina pectoris—Donepezil—Alzheimer's disease	0.000576	0.00274	CcSEcCtD
Ponatinib—Eye disorder—Galantamine—Alzheimer's disease	0.000571	0.00271	CcSEcCtD
Ponatinib—KIT—central nervous system—Alzheimer's disease	0.000571	0.00567	CbGeAlD
Ponatinib—Dry skin—Memantine—Alzheimer's disease	0.00057	0.0027	CcSEcCtD
Ponatinib—Abdominal discomfort—Donepezil—Alzheimer's disease	0.000567	0.00269	CcSEcCtD
Ponatinib—Cardiac disorder—Galantamine—Alzheimer's disease	0.000567	0.00269	CcSEcCtD
Ponatinib—Flushing—Galantamine—Alzheimer's disease	0.000567	0.00269	CcSEcCtD
Ponatinib—PDGFRA—brain—Alzheimer's disease	0.000567	0.00563	CbGeAlD
Ponatinib—Hypokalaemia—Memantine—Alzheimer's disease	0.000566	0.00269	CcSEcCtD
Ponatinib—Dehydration—Rivastigmine—Alzheimer's disease	0.000566	0.00268	CcSEcCtD
Ponatinib—ABCB1—blood vessel—Alzheimer's disease	0.00056	0.00556	CbGeAlD
Ponatinib—Aspartate aminotransferase increased—Memantine—Alzheimer's disease	0.00056	0.00266	CcSEcCtD
Ponatinib—KIT—cerebellum—Alzheimer's disease	0.000558	0.00554	CbGeAlD
Ponatinib—Dry skin—Rivastigmine—Alzheimer's disease	0.000557	0.00265	CcSEcCtD
Ponatinib—SRC—brain—Alzheimer's disease	0.000556	0.00552	CbGeAlD
Ponatinib—Nasopharyngitis—Memantine—Alzheimer's disease	0.000556	0.00264	CcSEcCtD
Ponatinib—Angiopathy—Galantamine—Alzheimer's disease	0.000555	0.00263	CcSEcCtD
Ponatinib—Hypokalaemia—Rivastigmine—Alzheimer's disease	0.000553	0.00263	CcSEcCtD
Ponatinib—ABCG2—telencephalon—Alzheimer's disease	0.000551	0.00547	CbGeAlD
Ponatinib—Breast disorder—Rivastigmine—Alzheimer's disease	0.00055	0.00261	CcSEcCtD
Ponatinib—Alanine aminotransferase increased—Memantine—Alzheimer's disease	0.000548	0.0026	CcSEcCtD
Ponatinib—Arrhythmia—Galantamine—Alzheimer's disease	0.000546	0.00259	CcSEcCtD
Ponatinib—Nasopharyngitis—Rivastigmine—Alzheimer's disease	0.000544	0.00258	CcSEcCtD
Ponatinib—Mental disorder—Galantamine—Alzheimer's disease	0.000535	0.00254	CcSEcCtD
Ponatinib—Weight decreased—Donepezil—Alzheimer's disease	0.000535	0.00254	CcSEcCtD
Ponatinib—Hyperglycaemia—Donepezil—Alzheimer's disease	0.000534	0.00253	CcSEcCtD
Ponatinib—Malnutrition—Galantamine—Alzheimer's disease	0.000532	0.00253	CcSEcCtD
Ponatinib—Pneumonia—Donepezil—Alzheimer's disease	0.000531	0.00252	CcSEcCtD
Ponatinib—Infestation NOS—Donepezil—Alzheimer's disease	0.000528	0.0025	CcSEcCtD
Ponatinib—Infestation—Donepezil—Alzheimer's disease	0.000528	0.0025	CcSEcCtD
Ponatinib—Pancreatitis—Memantine—Alzheimer's disease	0.000527	0.0025	CcSEcCtD
Ponatinib—Angina pectoris—Memantine—Alzheimer's disease	0.000523	0.00248	CcSEcCtD
Ponatinib—Imatinib—PTGS1—Alzheimer's disease	0.000521	0.0834	CrCbGaD
Ponatinib—Acute coronary syndrome—Donepezil—Alzheimer's disease	0.00052	0.00247	CcSEcCtD
Ponatinib—Myocardial infarction—Donepezil—Alzheimer's disease	0.000517	0.00246	CcSEcCtD
Ponatinib—ABL1—nervous system—Alzheimer's disease	0.000516	0.00512	CbGeAlD
Ponatinib—Pancreatitis—Rivastigmine—Alzheimer's disease	0.000515	0.00245	CcSEcCtD
Ponatinib—Back pain—Galantamine—Alzheimer's disease	0.000515	0.00244	CcSEcCtD
Ponatinib—Jaundice—Donepezil—Alzheimer's disease	0.000514	0.00244	CcSEcCtD
Ponatinib—Urinary tract infection—Donepezil—Alzheimer's disease	0.000513	0.00243	CcSEcCtD
Ponatinib—Angina pectoris—Rivastigmine—Alzheimer's disease	0.000512	0.00243	CcSEcCtD
Ponatinib—Muscle spasms—Galantamine—Alzheimer's disease	0.000512	0.00243	CcSEcCtD
Ponatinib—KDR—brain—Alzheimer's disease	0.000511	0.00508	CbGeAlD
Ponatinib—Pancytopenia—Memantine—Alzheimer's disease	0.00051	0.00242	CcSEcCtD
Ponatinib—Neutropenia—Memantine—Alzheimer's disease	0.000502	0.00239	CcSEcCtD
Ponatinib—Vision blurred—Galantamine—Alzheimer's disease	0.000501	0.00238	CcSEcCtD
Ponatinib—Upper respiratory tract infection—Memantine—Alzheimer's disease	0.000499	0.00237	CcSEcCtD
Ponatinib—Epistaxis—Donepezil—Alzheimer's disease	0.000498	0.00236	CcSEcCtD
Ponatinib—ABL1—central nervous system—Alzheimer's disease	0.000497	0.00493	CbGeAlD
Ponatinib—Erectile dysfunction—Memantine—Alzheimer's disease	0.000495	0.00235	CcSEcCtD
Ponatinib—Anaemia—Galantamine—Alzheimer's disease	0.000492	0.00233	CcSEcCtD
Ponatinib—Upper respiratory tract infection—Rivastigmine—Alzheimer's disease	0.000489	0.00232	CcSEcCtD
Ponatinib—Weight decreased—Memantine—Alzheimer's disease	0.000486	0.00231	CcSEcCtD
Ponatinib—ABL1—cerebellum—Alzheimer's disease	0.000486	0.00482	CbGeAlD
Ponatinib—Hyperglycaemia—Memantine—Alzheimer's disease	0.000485	0.0023	CcSEcCtD
Ponatinib—Erectile dysfunction—Rivastigmine—Alzheimer's disease	0.000484	0.0023	CcSEcCtD
Ponatinib—Pneumonia—Memantine—Alzheimer's disease	0.000482	0.00229	CcSEcCtD
Ponatinib—Infestation—Memantine—Alzheimer's disease	0.000479	0.00227	CcSEcCtD
Ponatinib—Infestation NOS—Memantine—Alzheimer's disease	0.000479	0.00227	CcSEcCtD
Ponatinib—Haemoglobin—Donepezil—Alzheimer's disease	0.000476	0.00226	CcSEcCtD
Ponatinib—Weight decreased—Rivastigmine—Alzheimer's disease	0.000476	0.00226	CcSEcCtD
Ponatinib—Hyperglycaemia—Rivastigmine—Alzheimer's disease	0.000474	0.00225	CcSEcCtD
Ponatinib—Haemorrhage—Donepezil—Alzheimer's disease	0.000474	0.00225	CcSEcCtD
Ponatinib—Acute coronary syndrome—Memantine—Alzheimer's disease	0.000472	0.00224	CcSEcCtD
Ponatinib—Pneumonia—Rivastigmine—Alzheimer's disease	0.000471	0.00224	CcSEcCtD
Ponatinib—Hypoaesthesia—Donepezil—Alzheimer's disease	0.000471	0.00224	CcSEcCtD
Ponatinib—Myocardial infarction—Memantine—Alzheimer's disease	0.00047	0.00223	CcSEcCtD
Ponatinib—Neuropathy peripheral—Memantine—Alzheimer's disease	0.00047	0.00223	CcSEcCtD
Ponatinib—Infestation NOS—Rivastigmine—Alzheimer's disease	0.000469	0.00222	CcSEcCtD
Ponatinib—Infestation—Rivastigmine—Alzheimer's disease	0.000469	0.00222	CcSEcCtD
Ponatinib—Oedema peripheral—Donepezil—Alzheimer's disease	0.000467	0.00221	CcSEcCtD
Ponatinib—Urinary tract infection—Memantine—Alzheimer's disease	0.000466	0.00221	CcSEcCtD
Ponatinib—Cough—Galantamine—Alzheimer's disease	0.000464	0.0022	CcSEcCtD
Ponatinib—Acute coronary syndrome—Rivastigmine—Alzheimer's disease	0.000462	0.00219	CcSEcCtD
Ponatinib—Neuropathy peripheral—Rivastigmine—Alzheimer's disease	0.000459	0.00218	CcSEcCtD
Ponatinib—Myocardial infarction—Rivastigmine—Alzheimer's disease	0.000459	0.00218	CcSEcCtD
Ponatinib—Hypertension—Galantamine—Alzheimer's disease	0.000459	0.00218	CcSEcCtD
Ponatinib—Visual impairment—Donepezil—Alzheimer's disease	0.000456	0.00217	CcSEcCtD
Ponatinib—Urinary tract infection—Rivastigmine—Alzheimer's disease	0.000456	0.00216	CcSEcCtD
Ponatinib—KIT—brain—Alzheimer's disease	0.000453	0.0045	CbGeAlD
Ponatinib—Hepatobiliary disease—Memantine—Alzheimer's disease	0.000453	0.00215	CcSEcCtD
Ponatinib—Arthralgia—Galantamine—Alzheimer's disease	0.000453	0.00215	CcSEcCtD
Ponatinib—Myalgia—Galantamine—Alzheimer's disease	0.000453	0.00215	CcSEcCtD
Ponatinib—Epistaxis—Memantine—Alzheimer's disease	0.000452	0.00215	CcSEcCtD
Ponatinib—Unspecified disorder of skin and subcutaneous tissue—Galantamine—Alzheimer's disease	0.00045	0.00214	CcSEcCtD
Ponatinib—Hepatobiliary disease—Rivastigmine—Alzheimer's disease	0.000443	0.0021	CcSEcCtD
Ponatinib—Dry mouth—Galantamine—Alzheimer's disease	0.000443	0.0021	CcSEcCtD
Ponatinib—Epistaxis—Rivastigmine—Alzheimer's disease	0.000442	0.0021	CcSEcCtD
Ponatinib—Haemoglobin—Memantine—Alzheimer's disease	0.000432	0.00205	CcSEcCtD
Ponatinib—Haemorrhage—Memantine—Alzheimer's disease	0.00043	0.00204	CcSEcCtD
Ponatinib—Hypoaesthesia—Memantine—Alzheimer's disease	0.000428	0.00203	CcSEcCtD
Ponatinib—Nervous system disorder—Galantamine—Alzheimer's disease	0.000426	0.00202	CcSEcCtD
Ponatinib—Nilotinib—CYP2D6—Alzheimer's disease	0.000425	0.0681	CrCbGaD
Ponatinib—Thrombocytopenia—Galantamine—Alzheimer's disease	0.000425	0.00202	CcSEcCtD
Ponatinib—Chills—Donepezil—Alzheimer's disease	0.000425	0.00202	CcSEcCtD
Ponatinib—Oedema peripheral—Memantine—Alzheimer's disease	0.000424	0.00201	CcSEcCtD
Ponatinib—Arrhythmia—Donepezil—Alzheimer's disease	0.000423	0.00201	CcSEcCtD
Ponatinib—Haemoglobin—Rivastigmine—Alzheimer's disease	0.000423	0.00201	CcSEcCtD
Ponatinib—Connective tissue disorder—Memantine—Alzheimer's disease	0.000423	0.00201	CcSEcCtD
Ponatinib—Skin disorder—Galantamine—Alzheimer's disease	0.000422	0.002	CcSEcCtD
Ponatinib—Haemorrhage—Rivastigmine—Alzheimer's disease	0.000421	0.002	CcSEcCtD
Ponatinib—Hyperhidrosis—Galantamine—Alzheimer's disease	0.00042	0.00199	CcSEcCtD
Ponatinib—Hypoaesthesia—Rivastigmine—Alzheimer's disease	0.000419	0.00199	CcSEcCtD
Ponatinib—Alopecia—Donepezil—Alzheimer's disease	0.000419	0.00199	CcSEcCtD
Ponatinib—Mental disorder—Donepezil—Alzheimer's disease	0.000415	0.00197	CcSEcCtD
Ponatinib—Oedema peripheral—Rivastigmine—Alzheimer's disease	0.000414	0.00197	CcSEcCtD
Ponatinib—Visual impairment—Memantine—Alzheimer's disease	0.000414	0.00197	CcSEcCtD
Ponatinib—Connective tissue disorder—Rivastigmine—Alzheimer's disease	0.000413	0.00196	CcSEcCtD
Ponatinib—Erythema—Donepezil—Alzheimer's disease	0.000412	0.00196	CcSEcCtD
Ponatinib—Malnutrition—Donepezil—Alzheimer's disease	0.000412	0.00196	CcSEcCtD
Ponatinib—CYP2D6—forebrain—Alzheimer's disease	0.000411	0.00408	CbGeAlD
Ponatinib—Visual impairment—Rivastigmine—Alzheimer's disease	0.000405	0.00192	CcSEcCtD
Ponatinib—Eye disorder—Memantine—Alzheimer's disease	0.000402	0.00191	CcSEcCtD
Ponatinib—Flushing—Memantine—Alzheimer's disease	0.000399	0.00189	CcSEcCtD
Ponatinib—Cardiac disorder—Memantine—Alzheimer's disease	0.000399	0.00189	CcSEcCtD
Ponatinib—Back pain—Donepezil—Alzheimer's disease	0.000399	0.00189	CcSEcCtD
Ponatinib—Muscle spasms—Donepezil—Alzheimer's disease	0.000396	0.00188	CcSEcCtD
Ponatinib—Musculoskeletal discomfort—Galantamine—Alzheimer's disease	0.000396	0.00188	CcSEcCtD
Ponatinib—ABL1—brain—Alzheimer's disease	0.000395	0.00392	CbGeAlD
Ponatinib—Eye disorder—Rivastigmine—Alzheimer's disease	0.000393	0.00187	CcSEcCtD
Ponatinib—Insomnia—Galantamine—Alzheimer's disease	0.000393	0.00186	CcSEcCtD
Ponatinib—Flushing—Rivastigmine—Alzheimer's disease	0.00039	0.00185	CcSEcCtD
Ponatinib—Cardiac disorder—Rivastigmine—Alzheimer's disease	0.00039	0.00185	CcSEcCtD
Ponatinib—Angiopathy—Memantine—Alzheimer's disease	0.00039	0.00185	CcSEcCtD
Ponatinib—Paraesthesia—Galantamine—Alzheimer's disease	0.00039	0.00185	CcSEcCtD
Ponatinib—Vision blurred—Donepezil—Alzheimer's disease	0.000389	0.00184	CcSEcCtD
Ponatinib—Mediastinal disorder—Memantine—Alzheimer's disease	0.000388	0.00184	CcSEcCtD
Ponatinib—Chills—Memantine—Alzheimer's disease	0.000386	0.00183	CcSEcCtD
Ponatinib—Arrhythmia—Memantine—Alzheimer's disease	0.000384	0.00182	CcSEcCtD
Ponatinib—Dyspepsia—Galantamine—Alzheimer's disease	0.000382	0.00181	CcSEcCtD
Ponatinib—Angiopathy—Rivastigmine—Alzheimer's disease	0.000382	0.00181	CcSEcCtD
Ponatinib—Anaemia—Donepezil—Alzheimer's disease	0.000381	0.00181	CcSEcCtD
Ponatinib—Alopecia—Memantine—Alzheimer's disease	0.00038	0.0018	CcSEcCtD
Ponatinib—Mediastinal disorder—Rivastigmine—Alzheimer's disease	0.000379	0.0018	CcSEcCtD
Ponatinib—CYP2D6—telencephalon—Alzheimer's disease	0.000378	0.00375	CbGeAlD
Ponatinib—Chills—Rivastigmine—Alzheimer's disease	0.000377	0.00179	CcSEcCtD
Ponatinib—Decreased appetite—Galantamine—Alzheimer's disease	0.000377	0.00179	CcSEcCtD
Ponatinib—Mental disorder—Memantine—Alzheimer's disease	0.000377	0.00179	CcSEcCtD
Ponatinib—Arrhythmia—Rivastigmine—Alzheimer's disease	0.000376	0.00178	CcSEcCtD
Ponatinib—Gastrointestinal disorder—Galantamine—Alzheimer's disease	0.000375	0.00178	CcSEcCtD
Ponatinib—Malnutrition—Memantine—Alzheimer's disease	0.000374	0.00178	CcSEcCtD
Ponatinib—Fatigue—Galantamine—Alzheimer's disease	0.000374	0.00178	CcSEcCtD
Ponatinib—Alopecia—Rivastigmine—Alzheimer's disease	0.000372	0.00176	CcSEcCtD
Ponatinib—Constipation—Galantamine—Alzheimer's disease	0.000371	0.00176	CcSEcCtD
Ponatinib—Mental disorder—Rivastigmine—Alzheimer's disease	0.000369	0.00175	CcSEcCtD
Ponatinib—Malnutrition—Rivastigmine—Alzheimer's disease	0.000366	0.00174	CcSEcCtD
Ponatinib—Erythema—Rivastigmine—Alzheimer's disease	0.000366	0.00174	CcSEcCtD
Ponatinib—Back pain—Memantine—Alzheimer's disease	0.000362	0.00172	CcSEcCtD
Ponatinib—Cough—Donepezil—Alzheimer's disease	0.00036	0.00171	CcSEcCtD
Ponatinib—Hypertension—Donepezil—Alzheimer's disease	0.000356	0.00169	CcSEcCtD
Ponatinib—Gastrointestinal pain—Galantamine—Alzheimer's disease	0.000355	0.00169	CcSEcCtD
Ponatinib—Imatinib—CYP2D6—Alzheimer's disease	0.000355	0.0568	CrCbGaD
Ponatinib—Back pain—Rivastigmine—Alzheimer's disease	0.000354	0.00168	CcSEcCtD
Ponatinib—Vision blurred—Memantine—Alzheimer's disease	0.000353	0.00167	CcSEcCtD
Ponatinib—Muscle spasms—Rivastigmine—Alzheimer's disease	0.000352	0.00167	CcSEcCtD
Ponatinib—Myalgia—Donepezil—Alzheimer's disease	0.000351	0.00167	CcSEcCtD
Ponatinib—Arthralgia—Donepezil—Alzheimer's disease	0.000351	0.00167	CcSEcCtD
Ponatinib—Anaemia—Memantine—Alzheimer's disease	0.000346	0.00164	CcSEcCtD
Ponatinib—Vision blurred—Rivastigmine—Alzheimer's disease	0.000345	0.00164	CcSEcCtD
Ponatinib—Dry mouth—Donepezil—Alzheimer's disease	0.000343	0.00163	CcSEcCtD
Ponatinib—Body temperature increased—Galantamine—Alzheimer's disease	0.000343	0.00163	CcSEcCtD
Ponatinib—Abdominal pain—Galantamine—Alzheimer's disease	0.000343	0.00163	CcSEcCtD
Ponatinib—Anaemia—Rivastigmine—Alzheimer's disease	0.000339	0.00161	CcSEcCtD
Ponatinib—Oedema—Donepezil—Alzheimer's disease	0.000337	0.0016	CcSEcCtD
Ponatinib—Leukopenia—Memantine—Alzheimer's disease	0.000335	0.00159	CcSEcCtD
Ponatinib—Infection—Donepezil—Alzheimer's disease	0.000334	0.00159	CcSEcCtD
Ponatinib—ABCB1—embryo—Alzheimer's disease	0.000334	0.00332	CbGeAlD
Ponatinib—Nervous system disorder—Donepezil—Alzheimer's disease	0.00033	0.00157	CcSEcCtD
Ponatinib—Thrombocytopenia—Donepezil—Alzheimer's disease	0.000329	0.00156	CcSEcCtD
Ponatinib—Cough—Memantine—Alzheimer's disease	0.000327	0.00155	CcSEcCtD
Ponatinib—Hyperhidrosis—Donepezil—Alzheimer's disease	0.000325	0.00154	CcSEcCtD
Ponatinib—Hypertension—Memantine—Alzheimer's disease	0.000323	0.00153	CcSEcCtD
Ponatinib—Cough—Rivastigmine—Alzheimer's disease	0.00032	0.00152	CcSEcCtD
Ponatinib—Arthralgia—Memantine—Alzheimer's disease	0.000319	0.00151	CcSEcCtD
Ponatinib—Myalgia—Memantine—Alzheimer's disease	0.000319	0.00151	CcSEcCtD
Ponatinib—Hypertension—Rivastigmine—Alzheimer's disease	0.000316	0.0015	CcSEcCtD
Ponatinib—Myalgia—Rivastigmine—Alzheimer's disease	0.000312	0.00148	CcSEcCtD
Ponatinib—Arthralgia—Rivastigmine—Alzheimer's disease	0.000312	0.00148	CcSEcCtD
Ponatinib—Dry mouth—Memantine—Alzheimer's disease	0.000312	0.00148	CcSEcCtD
Ponatinib—Asthenia—Galantamine—Alzheimer's disease	0.000312	0.00148	CcSEcCtD
Ponatinib—Unspecified disorder of skin and subcutaneous tissue—Rivastigmine—Alzheimer's disease	0.00031	0.00147	CcSEcCtD
Ponatinib—Musculoskeletal discomfort—Donepezil—Alzheimer's disease	0.000307	0.00146	CcSEcCtD
Ponatinib—ABCG2—cerebellum—Alzheimer's disease	0.000306	0.00304	CbGeAlD
Ponatinib—Oedema—Memantine—Alzheimer's disease	0.000306	0.00145	CcSEcCtD
Ponatinib—Dry mouth—Rivastigmine—Alzheimer's disease	0.000305	0.00145	CcSEcCtD
Ponatinib—Insomnia—Donepezil—Alzheimer's disease	0.000304	0.00144	CcSEcCtD
Ponatinib—Infection—Memantine—Alzheimer's disease	0.000304	0.00144	CcSEcCtD
Ponatinib—Paraesthesia—Donepezil—Alzheimer's disease	0.000302	0.00143	CcSEcCtD
Ponatinib—Dyspnoea—Donepezil—Alzheimer's disease	0.0003	0.00142	CcSEcCtD
Ponatinib—Nervous system disorder—Memantine—Alzheimer's disease	0.0003	0.00142	CcSEcCtD
Ponatinib—Thrombocytopenia—Memantine—Alzheimer's disease	0.000299	0.00142	CcSEcCtD
Ponatinib—Oedema—Rivastigmine—Alzheimer's disease	0.000299	0.00142	CcSEcCtD
Ponatinib—Diarrhoea—Galantamine—Alzheimer's disease	0.000297	0.00141	CcSEcCtD
Ponatinib—Infection—Rivastigmine—Alzheimer's disease	0.000297	0.00141	CcSEcCtD
Ponatinib—Skin disorder—Memantine—Alzheimer's disease	0.000297	0.00141	CcSEcCtD
Ponatinib—Dyspepsia—Donepezil—Alzheimer's disease	0.000296	0.00141	CcSEcCtD
Ponatinib—ABCB1—forebrain—Alzheimer's disease	0.000296	0.00294	CbGeAlD
Ponatinib—Hyperhidrosis—Memantine—Alzheimer's disease	0.000295	0.0014	CcSEcCtD
Ponatinib—Nervous system disorder—Rivastigmine—Alzheimer's disease	0.000293	0.00139	CcSEcCtD
Ponatinib—Thrombocytopenia—Rivastigmine—Alzheimer's disease	0.000293	0.00139	CcSEcCtD
Ponatinib—Decreased appetite—Donepezil—Alzheimer's disease	0.000293	0.00139	CcSEcCtD
Ponatinib—Gastrointestinal disorder—Donepezil—Alzheimer's disease	0.000291	0.00138	CcSEcCtD
Ponatinib—Skin disorder—Rivastigmine—Alzheimer's disease	0.00029	0.00138	CcSEcCtD
Ponatinib—Fatigue—Donepezil—Alzheimer's disease	0.00029	0.00138	CcSEcCtD
Ponatinib—Hyperhidrosis—Rivastigmine—Alzheimer's disease	0.000289	0.00137	CcSEcCtD
Ponatinib—Pain—Donepezil—Alzheimer's disease	0.000288	0.00137	CcSEcCtD
Ponatinib—Constipation—Donepezil—Alzheimer's disease	0.000288	0.00137	CcSEcCtD
Ponatinib—Dizziness—Galantamine—Alzheimer's disease	0.000287	0.00136	CcSEcCtD
Ponatinib—Musculoskeletal discomfort—Memantine—Alzheimer's disease	0.000278	0.00132	CcSEcCtD
Ponatinib—Insomnia—Memantine—Alzheimer's disease	0.000276	0.00131	CcSEcCtD
Ponatinib—Vomiting—Galantamine—Alzheimer's disease	0.000276	0.00131	CcSEcCtD
Ponatinib—Gastrointestinal pain—Donepezil—Alzheimer's disease	0.000275	0.00131	CcSEcCtD
Ponatinib—Paraesthesia—Memantine—Alzheimer's disease	0.000274	0.0013	CcSEcCtD
Ponatinib—Rash—Galantamine—Alzheimer's disease	0.000274	0.0013	CcSEcCtD
Ponatinib—Dermatitis—Galantamine—Alzheimer's disease	0.000274	0.0013	CcSEcCtD
Ponatinib—Dyspnoea—Memantine—Alzheimer's disease	0.000272	0.00129	CcSEcCtD
Ponatinib—Musculoskeletal discomfort—Rivastigmine—Alzheimer's disease	0.000272	0.00129	CcSEcCtD
Ponatinib—Headache—Galantamine—Alzheimer's disease	0.000272	0.00129	CcSEcCtD
Ponatinib—ABCB1—telencephalon—Alzheimer's disease	0.000272	0.0027	CbGeAlD
Ponatinib—Insomnia—Rivastigmine—Alzheimer's disease	0.00027	0.00128	CcSEcCtD
Ponatinib—Dyspepsia—Memantine—Alzheimer's disease	0.000269	0.00128	CcSEcCtD
Ponatinib—Paraesthesia—Rivastigmine—Alzheimer's disease	0.000268	0.00127	CcSEcCtD
Ponatinib—Dyspnoea—Rivastigmine—Alzheimer's disease	0.000266	0.00127	CcSEcCtD
Ponatinib—Body temperature increased—Donepezil—Alzheimer's disease	0.000266	0.00126	CcSEcCtD
Ponatinib—Abdominal pain—Donepezil—Alzheimer's disease	0.000266	0.00126	CcSEcCtD
Ponatinib—Decreased appetite—Memantine—Alzheimer's disease	0.000266	0.00126	CcSEcCtD
Ponatinib—Gastrointestinal disorder—Memantine—Alzheimer's disease	0.000264	0.00125	CcSEcCtD
Ponatinib—Fatigue—Memantine—Alzheimer's disease	0.000263	0.00125	CcSEcCtD
Ponatinib—Dyspepsia—Rivastigmine—Alzheimer's disease	0.000263	0.00125	CcSEcCtD
Ponatinib—Pain—Memantine—Alzheimer's disease	0.000261	0.00124	CcSEcCtD
Ponatinib—Constipation—Memantine—Alzheimer's disease	0.000261	0.00124	CcSEcCtD
Ponatinib—Decreased appetite—Rivastigmine—Alzheimer's disease	0.00026	0.00123	CcSEcCtD
Ponatinib—Gastrointestinal disorder—Rivastigmine—Alzheimer's disease	0.000258	0.00123	CcSEcCtD
Ponatinib—Nausea—Galantamine—Alzheimer's disease	0.000258	0.00122	CcSEcCtD
Ponatinib—Fatigue—Rivastigmine—Alzheimer's disease	0.000258	0.00122	CcSEcCtD
Ponatinib—CYP2C8—brain—Alzheimer's disease	0.000256	0.00254	CbGeAlD
Ponatinib—Pain—Rivastigmine—Alzheimer's disease	0.000256	0.00121	CcSEcCtD
Ponatinib—Constipation—Rivastigmine—Alzheimer's disease	0.000256	0.00121	CcSEcCtD
Ponatinib—Gastrointestinal pain—Memantine—Alzheimer's disease	0.00025	0.00119	CcSEcCtD
Ponatinib—ABCG2—brain—Alzheimer's disease	0.000249	0.00247	CbGeAlD
Ponatinib—Gastrointestinal pain—Rivastigmine—Alzheimer's disease	0.000244	0.00116	CcSEcCtD
Ponatinib—Abdominal pain—Memantine—Alzheimer's disease	0.000242	0.00115	CcSEcCtD
Ponatinib—Body temperature increased—Memantine—Alzheimer's disease	0.000242	0.00115	CcSEcCtD
Ponatinib—Asthenia—Donepezil—Alzheimer's disease	0.000241	0.00115	CcSEcCtD
Ponatinib—Pruritus—Donepezil—Alzheimer's disease	0.000238	0.00113	CcSEcCtD
Ponatinib—Body temperature increased—Rivastigmine—Alzheimer's disease	0.000236	0.00112	CcSEcCtD
Ponatinib—Abdominal pain—Rivastigmine—Alzheimer's disease	0.000236	0.00112	CcSEcCtD
Ponatinib—Diarrhoea—Donepezil—Alzheimer's disease	0.00023	0.00109	CcSEcCtD
Ponatinib—CYP3A4—nervous system—Alzheimer's disease	0.000227	0.00225	CbGeAlD
Ponatinib—CYP2D6—nervous system—Alzheimer's disease	0.000223	0.00222	CbGeAlD
Ponatinib—Dizziness—Donepezil—Alzheimer's disease	0.000223	0.00106	CcSEcCtD
Ponatinib—Asthenia—Memantine—Alzheimer's disease	0.000219	0.00104	CcSEcCtD
Ponatinib—CYP3A4—central nervous system—Alzheimer's disease	0.000218	0.00217	CbGeAlD
Ponatinib—Pruritus—Memantine—Alzheimer's disease	0.000216	0.00103	CcSEcCtD
Ponatinib—CYP2D6—central nervous system—Alzheimer's disease	0.000215	0.00213	CbGeAlD
Ponatinib—Asthenia—Rivastigmine—Alzheimer's disease	0.000214	0.00102	CcSEcCtD
Ponatinib—Vomiting—Donepezil—Alzheimer's disease	0.000214	0.00102	CcSEcCtD
Ponatinib—Rash—Donepezil—Alzheimer's disease	0.000212	0.00101	CcSEcCtD
Ponatinib—Dermatitis—Donepezil—Alzheimer's disease	0.000212	0.00101	CcSEcCtD
Ponatinib—Pruritus—Rivastigmine—Alzheimer's disease	0.000211	0.001	CcSEcCtD
Ponatinib—Headache—Donepezil—Alzheimer's disease	0.000211	0.001	CcSEcCtD
Ponatinib—CYP2D6—cerebellum—Alzheimer's disease	0.00021	0.00208	CbGeAlD
Ponatinib—Diarrhoea—Memantine—Alzheimer's disease	0.000209	0.000992	CcSEcCtD
Ponatinib—Diarrhoea—Rivastigmine—Alzheimer's disease	0.000205	0.000971	CcSEcCtD
Ponatinib—Dizziness—Memantine—Alzheimer's disease	0.000202	0.000959	CcSEcCtD
Ponatinib—Nausea—Donepezil—Alzheimer's disease	0.0002	0.000949	CcSEcCtD
Ponatinib—Dizziness—Rivastigmine—Alzheimer's disease	0.000198	0.000938	CcSEcCtD
Ponatinib—Vomiting—Memantine—Alzheimer's disease	0.000194	0.000922	CcSEcCtD
Ponatinib—Rash—Memantine—Alzheimer's disease	0.000193	0.000915	CcSEcCtD
Ponatinib—Dermatitis—Memantine—Alzheimer's disease	0.000192	0.000914	CcSEcCtD
Ponatinib—Headache—Memantine—Alzheimer's disease	0.000191	0.000909	CcSEcCtD
Ponatinib—Vomiting—Rivastigmine—Alzheimer's disease	0.00019	0.000902	CcSEcCtD
Ponatinib—Rash—Rivastigmine—Alzheimer's disease	0.000188	0.000895	CcSEcCtD
Ponatinib—Dermatitis—Rivastigmine—Alzheimer's disease	0.000188	0.000894	CcSEcCtD
Ponatinib—Headache—Rivastigmine—Alzheimer's disease	0.000187	0.000889	CcSEcCtD
Ponatinib—Nausea—Memantine—Alzheimer's disease	0.000181	0.000862	CcSEcCtD
Ponatinib—Nausea—Rivastigmine—Alzheimer's disease	0.000178	0.000843	CcSEcCtD
Ponatinib—CYP2D6—brain—Alzheimer's disease	0.000171	0.00169	CbGeAlD
Ponatinib—ABCB1—nervous system—Alzheimer's disease	0.000161	0.00159	CbGeAlD
Ponatinib—ABCB1—central nervous system—Alzheimer's disease	0.000155	0.00153	CbGeAlD
Ponatinib—ABCB1—cerebellum—Alzheimer's disease	0.000151	0.0015	CbGeAlD
Ponatinib—ABCB1—brain—Alzheimer's disease	0.000123	0.00122	CbGeAlD
Ponatinib—ABL1—Immune System—MAPK8—Alzheimer's disease	3.89e-06	1.7e-05	CbGpPWpGaD
Ponatinib—SRC—Disease—GSK3B—Alzheimer's disease	3.88e-06	1.7e-05	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—NOS3—Alzheimer's disease	3.88e-06	1.7e-05	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism—ABCA1—Alzheimer's disease	3.88e-06	1.7e-05	CbGpPWpGaD
Ponatinib—FGFR4—Signaling Pathways—IL6—Alzheimer's disease	3.87e-06	1.69e-05	CbGpPWpGaD
Ponatinib—CYP3A5—Metabolism—PPARGC1A—Alzheimer's disease	3.86e-06	1.69e-05	CbGpPWpGaD
Ponatinib—SRC—Disease—CREB1—Alzheimer's disease	3.85e-06	1.69e-05	CbGpPWpGaD
Ponatinib—CYP3A5—Metabolism—HMOX1—Alzheimer's disease	3.84e-06	1.68e-05	CbGpPWpGaD
Ponatinib—SRC—Disease—INS—Alzheimer's disease	3.83e-06	1.68e-05	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—HTR2A—Alzheimer's disease	3.81e-06	1.67e-05	CbGpPWpGaD
Ponatinib—FGFR3—Signaling Pathways—TGFB1—Alzheimer's disease	3.8e-06	1.66e-05	CbGpPWpGaD
Ponatinib—LYN—Adaptive Immune System—AKT1—Alzheimer's disease	3.8e-06	1.66e-05	CbGpPWpGaD
Ponatinib—LCK—Disease—NOS3—Alzheimer's disease	3.79e-06	1.66e-05	CbGpPWpGaD
Ponatinib—SRC—Hemostasis—TP53—Alzheimer's disease	3.78e-06	1.65e-05	CbGpPWpGaD
Ponatinib—FGFR3—Disease—AKT1—Alzheimer's disease	3.77e-06	1.65e-05	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—GSK3B—Alzheimer's disease	3.75e-06	1.64e-05	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—LPL—Alzheimer's disease	3.74e-06	1.64e-05	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—ENO1—Alzheimer's disease	3.74e-06	1.64e-05	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—PTGS1—Alzheimer's disease	3.74e-06	1.64e-05	CbGpPWpGaD
Ponatinib—FGFR2—Disease—TGFB1—Alzheimer's disease	3.73e-06	1.63e-05	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—CREB1—Alzheimer's disease	3.72e-06	1.63e-05	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—MEF2C—Alzheimer's disease	3.71e-06	1.62e-05	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—INS—Alzheimer's disease	3.7e-06	1.62e-05	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—BCHE—Alzheimer's disease	3.69e-06	1.62e-05	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—NOS3—Alzheimer's disease	3.68e-06	1.61e-05	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—NOS3—Alzheimer's disease	3.67e-06	1.61e-05	CbGpPWpGaD
Ponatinib—KIT—Disease—TGFB1—Alzheimer's disease	3.67e-06	1.6e-05	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—PRKCG—Alzheimer's disease	3.64e-06	1.59e-05	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—CCL2—Alzheimer's disease	3.64e-06	1.59e-05	CbGpPWpGaD
Ponatinib—KDR—Signaling Pathways—VEGFA—Alzheimer's disease	3.61e-06	1.58e-05	CbGpPWpGaD
Ponatinib—LCK—Hemostasis—AKT1—Alzheimer's disease	3.6e-06	1.58e-05	CbGpPWpGaD
Ponatinib—ABCG2—Metabolism—PPARG—Alzheimer's disease	3.58e-06	1.57e-05	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—IGF1—Alzheimer's disease	3.57e-06	1.56e-05	CbGpPWpGaD
Ponatinib—FGFR4—Signaling Pathways—AKT1—Alzheimer's disease	3.57e-06	1.56e-05	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—CALM1—Alzheimer's disease	3.56e-06	1.56e-05	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—NGF—Alzheimer's disease	3.55e-06	1.55e-05	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—LEP—Alzheimer's disease	3.55e-06	1.55e-05	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—APOE—Alzheimer's disease	3.55e-06	1.55e-05	CbGpPWpGaD
Ponatinib—SRC—Developmental Biology—IL6—Alzheimer's disease	3.52e-06	1.54e-05	CbGpPWpGaD
Ponatinib—LCK—Innate Immune System—IL6—Alzheimer's disease	3.51e-06	1.54e-05	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—CAV1—Alzheimer's disease	3.51e-06	1.54e-05	CbGpPWpGaD
Ponatinib—CYP3A5—Metabolism—LPL—Alzheimer's disease	3.51e-06	1.54e-05	CbGpPWpGaD
Ponatinib—ABCG2—Metabolism—INS—Alzheimer's disease	3.51e-06	1.54e-05	CbGpPWpGaD
Ponatinib—SRC—Immune System—BCL2—Alzheimer's disease	3.5e-06	1.53e-05	CbGpPWpGaD
Ponatinib—LCK—Immune System—IL1B—Alzheimer's disease	3.5e-06	1.53e-05	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—PLCB1—Alzheimer's disease	3.48e-06	1.52e-05	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—BCHE—Alzheimer's disease	3.48e-06	1.52e-05	CbGpPWpGaD
Ponatinib—FGFR1—Disease—TGFB1—Alzheimer's disease	3.48e-06	1.52e-05	CbGpPWpGaD
Ponatinib—LCK—Disease—PTGS2—Alzheimer's disease	3.47e-06	1.52e-05	CbGpPWpGaD
Ponatinib—PDGFRA—Disease—TGFB1—Alzheimer's disease	3.47e-06	1.52e-05	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—CCR5—Alzheimer's disease	3.45e-06	1.51e-05	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—ESR1—Alzheimer's disease	3.39e-06	1.48e-05	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—ABCA1—Alzheimer's disease	3.38e-06	1.48e-05	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—HTR2A—Alzheimer's disease	3.38e-06	1.48e-05	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—TPI1—Alzheimer's disease	3.37e-06	1.47e-05	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—CHAT—Alzheimer's disease	3.37e-06	1.47e-05	CbGpPWpGaD
Ponatinib—SRC—Disease—NOS3—Alzheimer's disease	3.36e-06	1.47e-05	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—CASP3—Alzheimer's disease	3.36e-06	1.47e-05	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—F2—Alzheimer's disease	3.34e-06	1.46e-05	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism—PPARGC1A—Alzheimer's disease	3.34e-06	1.46e-05	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism—HMOX1—Alzheimer's disease	3.33e-06	1.46e-05	CbGpPWpGaD
Ponatinib—KDR—Signaling Pathways—TGFB1—Alzheimer's disease	3.31e-06	1.45e-05	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—CASP3—Alzheimer's disease	3.3e-06	1.44e-05	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—PLCB1—Alzheimer's disease	3.28e-06	1.44e-05	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—NOTCH1—Alzheimer's disease	3.27e-06	1.43e-05	CbGpPWpGaD
Ponatinib—SRC—Developmental Biology—AKT1—Alzheimer's disease	3.25e-06	1.42e-05	CbGpPWpGaD
Ponatinib—LCK—Innate Immune System—AKT1—Alzheimer's disease	3.24e-06	1.42e-05	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—NOS3—Alzheimer's disease	3.24e-06	1.42e-05	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—MAOB—Alzheimer's disease	3.23e-06	1.41e-05	CbGpPWpGaD
Ponatinib—LCK—Immune System—MAPK8—Alzheimer's disease	3.21e-06	1.4e-05	CbGpPWpGaD
Ponatinib—SRC—Hemostasis—AKT1—Alzheimer's disease	3.19e-06	1.4e-05	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—ABCA1—Alzheimer's disease	3.18e-06	1.39e-05	CbGpPWpGaD
Ponatinib—CYP3A5—Metabolism—MTHFR—Alzheimer's disease	3.16e-06	1.38e-05	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—CALM1—Alzheimer's disease	3.15e-06	1.38e-05	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—APOE—Alzheimer's disease	3.14e-06	1.37e-05	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—LEP—Alzheimer's disease	3.14e-06	1.37e-05	CbGpPWpGaD
Ponatinib—FGFR3—Signaling Pathways—TP53—Alzheimer's disease	3.13e-06	1.37e-05	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—CASP3—Alzheimer's disease	3.13e-06	1.37e-05	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—CASP3—Alzheimer's disease	3.12e-06	1.37e-05	CbGpPWpGaD
Ponatinib—LCK—Adaptive Immune System—AKT1—Alzheimer's disease	3.11e-06	1.36e-05	CbGpPWpGaD
Ponatinib—SRC—Innate Immune System—IL6—Alzheimer's disease	3.11e-06	1.36e-05	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—CAV1—Alzheimer's disease	3.11e-06	1.36e-05	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—GAPDH—Alzheimer's disease	3.11e-06	1.36e-05	CbGpPWpGaD
Ponatinib—SRC—Immune System—IL1B—Alzheimer's disease	3.1e-06	1.35e-05	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—MAPK8—Alzheimer's disease	3.08e-06	1.35e-05	CbGpPWpGaD
Ponatinib—ABCG2—Metabolism—NOS3—Alzheimer's disease	3.08e-06	1.35e-05	CbGpPWpGaD
Ponatinib—SRC—Disease—PTGS2—Alzheimer's disease	3.07e-06	1.34e-05	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—GSK3B—Alzheimer's disease	3.07e-06	1.34e-05	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—CREB1—Alzheimer's disease	3.05e-06	1.33e-05	CbGpPWpGaD
Ponatinib—FGFR2—Immune System—IL6—Alzheimer's disease	3.05e-06	1.33e-05	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism—LPL—Alzheimer's disease	3.04e-06	1.33e-05	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—INS—Alzheimer's disease	3.03e-06	1.33e-05	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—MAPK8—Alzheimer's disease	3.03e-06	1.33e-05	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—A2M—Alzheimer's disease	3e-06	1.31e-05	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—ESR1—Alzheimer's disease	3e-06	1.31e-05	CbGpPWpGaD
Ponatinib—KIT—Immune System—IL6—Alzheimer's disease	2.99e-06	1.31e-05	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—CCL2—Alzheimer's disease	2.98e-06	1.3e-05	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—F2—Alzheimer's disease	2.96e-06	1.3e-05	CbGpPWpGaD
Ponatinib—CYP3A5—Metabolism—CALM1—Alzheimer's disease	2.95e-06	1.29e-05	CbGpPWpGaD
Ponatinib—CYP3A5—Metabolism—APOE—Alzheimer's disease	2.94e-06	1.29e-05	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—IGF1—Alzheimer's disease	2.93e-06	1.28e-05	CbGpPWpGaD
Ponatinib—CYP3A5—Metabolism—CAV1—Alzheimer's disease	2.92e-06	1.28e-05	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—PPARGC1A—Alzheimer's disease	2.91e-06	1.27e-05	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—HMOX1—Alzheimer's disease	2.9e-06	1.27e-05	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—NOTCH1—Alzheimer's disease	2.9e-06	1.27e-05	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—MAPK8—Alzheimer's disease	2.87e-06	1.26e-05	CbGpPWpGaD
Ponatinib—SRC—Innate Immune System—AKT1—Alzheimer's disease	2.87e-06	1.26e-05	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—MAPK8—Alzheimer's disease	2.87e-06	1.25e-05	CbGpPWpGaD
Ponatinib—FGFR3—Signaling Pathways—IL6—Alzheimer's disease	2.86e-06	1.25e-05	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—VEGFA—Alzheimer's disease	2.85e-06	1.25e-05	CbGpPWpGaD
Ponatinib—FGFR1—Immune System—IL6—Alzheimer's disease	2.84e-06	1.24e-05	CbGpPWpGaD
Ponatinib—SRC—Immune System—MAPK8—Alzheimer's disease	2.84e-06	1.24e-05	CbGpPWpGaD
Ponatinib—PDGFRA—Immune System—IL6—Alzheimer's disease	2.83e-06	1.24e-05	CbGpPWpGaD
Ponatinib—ABCG2—Metabolism—PTGS2—Alzheimer's disease	2.81e-06	1.23e-05	CbGpPWpGaD
Ponatinib—FGFR2—Disease—IL6—Alzheimer's disease	2.81e-06	1.23e-05	CbGpPWpGaD
Ponatinib—FGFR2—Immune System—AKT1—Alzheimer's disease	2.81e-06	1.23e-05	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—VEGFA—Alzheimer's disease	2.8e-06	1.22e-05	CbGpPWpGaD
Ponatinib—KIT—Disease—IL6—Alzheimer's disease	2.76e-06	1.21e-05	CbGpPWpGaD
Ponatinib—KIT—Immune System—AKT1—Alzheimer's disease	2.76e-06	1.21e-05	CbGpPWpGaD
Ponatinib—SRC—Adaptive Immune System—AKT1—Alzheimer's disease	2.76e-06	1.21e-05	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—CASP3—Alzheimer's disease	2.75e-06	1.2e-05	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—PPARGC1A—Alzheimer's disease	2.74e-06	1.2e-05	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism—MTHFR—Alzheimer's disease	2.74e-06	1.2e-05	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—HMOX1—Alzheimer's disease	2.73e-06	1.19e-05	CbGpPWpGaD
Ponatinib—KDR—Signaling Pathways—TP53—Alzheimer's disease	2.72e-06	1.19e-05	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—GSK3B—Alzheimer's disease	2.72e-06	1.19e-05	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—CREB1—Alzheimer's disease	2.7e-06	1.18e-05	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—INS—Alzheimer's disease	2.68e-06	1.17e-05	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—NOS3—Alzheimer's disease	2.66e-06	1.16e-05	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—VEGFA—Alzheimer's disease	2.65e-06	1.16e-05	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—LPL—Alzheimer's disease	2.65e-06	1.16e-05	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—VEGFA—Alzheimer's disease	2.65e-06	1.16e-05	CbGpPWpGaD
Ponatinib—FGFR3—Signaling Pathways—AKT1—Alzheimer's disease	2.64e-06	1.16e-05	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—CCL2—Alzheimer's disease	2.64e-06	1.15e-05	CbGpPWpGaD
Ponatinib—FGFR1—Disease—IL6—Alzheimer's disease	2.62e-06	1.15e-05	CbGpPWpGaD
Ponatinib—FGFR1—Immune System—AKT1—Alzheimer's disease	2.62e-06	1.15e-05	CbGpPWpGaD
Ponatinib—PDGFRA—Disease—IL6—Alzheimer's disease	2.61e-06	1.14e-05	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—TGFB1—Alzheimer's disease	2.61e-06	1.14e-05	CbGpPWpGaD
Ponatinib—PDGFRA—Immune System—AKT1—Alzheimer's disease	2.61e-06	1.14e-05	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—ACHE—Alzheimer's disease	2.61e-06	1.14e-05	CbGpPWpGaD
Ponatinib—FGFR2—Disease—AKT1—Alzheimer's disease	2.59e-06	1.14e-05	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—IGF1—Alzheimer's disease	2.59e-06	1.14e-05	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—INPP5D—Alzheimer's disease	2.58e-06	1.13e-05	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—TGFB1—Alzheimer's disease	2.57e-06	1.12e-05	CbGpPWpGaD
Ponatinib—CYP3A5—Metabolism—PPARG—Alzheimer's disease	2.56e-06	1.12e-05	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism—CALM1—Alzheimer's disease	2.56e-06	1.12e-05	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism—APOE—Alzheimer's disease	2.55e-06	1.12e-05	CbGpPWpGaD
Ponatinib—KIT—Disease—AKT1—Alzheimer's disease	2.55e-06	1.12e-05	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—MAPK8—Alzheimer's disease	2.53e-06	1.11e-05	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism—CAV1—Alzheimer's disease	2.53e-06	1.11e-05	CbGpPWpGaD
Ponatinib—CYP3A5—Metabolism—INS—Alzheimer's disease	2.51e-06	1.1e-05	CbGpPWpGaD
Ponatinib—LCK—Disease—TGFB1—Alzheimer's disease	2.51e-06	1.1e-05	CbGpPWpGaD
Ponatinib—LYN—Immune System—IL6—Alzheimer's disease	2.5e-06	1.09e-05	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—LPL—Alzheimer's disease	2.5e-06	1.09e-05	CbGpPWpGaD
Ponatinib—KDR—Signaling Pathways—IL6—Alzheimer's disease	2.49e-06	1.09e-05	CbGpPWpGaD
Ponatinib—ABL1—Immune System—IL6—Alzheimer's disease	2.49e-06	1.09e-05	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—ENO1—Alzheimer's disease	2.45e-06	1.07e-05	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—PTGS1—Alzheimer's disease	2.45e-06	1.07e-05	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—TGFB1—Alzheimer's disease	2.44e-06	1.07e-05	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—TGFB1—Alzheimer's disease	2.43e-06	1.06e-05	CbGpPWpGaD
Ponatinib—FGFR1—Disease—AKT1—Alzheimer's disease	2.42e-06	1.06e-05	CbGpPWpGaD
Ponatinib—PDGFRA—Disease—AKT1—Alzheimer's disease	2.41e-06	1.06e-05	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—CYP2D6—Alzheimer's disease	2.4e-06	1.05e-05	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—MTHFR—Alzheimer's disease	2.39e-06	1.04e-05	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—NOS3—Alzheimer's disease	2.35e-06	1.03e-05	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—VEGFA—Alzheimer's disease	2.33e-06	1.02e-05	CbGpPWpGaD
Ponatinib—LYN—Immune System—AKT1—Alzheimer's disease	2.3e-06	1.01e-05	CbGpPWpGaD
Ponatinib—KDR—Signaling Pathways—AKT1—Alzheimer's disease	2.3e-06	1.01e-05	CbGpPWpGaD
Ponatinib—ABL1—Immune System—AKT1—Alzheimer's disease	2.29e-06	1e-05	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—BCHE—Alzheimer's disease	2.27e-06	9.95e-06	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—CASP3—Alzheimer's disease	2.26e-06	9.87e-06	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—MTHFR—Alzheimer's disease	2.25e-06	9.84e-06	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—CALM1—Alzheimer's disease	2.23e-06	9.75e-06	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—APOE—Alzheimer's disease	2.22e-06	9.72e-06	CbGpPWpGaD
Ponatinib—SRC—Disease—TGFB1—Alzheimer's disease	2.22e-06	9.72e-06	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism—PPARG—Alzheimer's disease	2.22e-06	9.72e-06	CbGpPWpGaD
Ponatinib—CYP3A5—Metabolism—NOS3—Alzheimer's disease	2.21e-06	9.65e-06	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—CAV1—Alzheimer's disease	2.2e-06	9.63e-06	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism—INS—Alzheimer's disease	2.18e-06	9.53e-06	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—TP53—Alzheimer's disease	2.15e-06	9.42e-06	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—PLCB1—Alzheimer's disease	2.15e-06	9.39e-06	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—TGFB1—Alzheimer's disease	2.14e-06	9.38e-06	CbGpPWpGaD
Ponatinib—ABCB11—Metabolism—AKT1—Alzheimer's disease	2.14e-06	9.37e-06	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—TP53—Alzheimer's disease	2.11e-06	9.25e-06	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—CALM1—Alzheimer's disease	2.1e-06	9.19e-06	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—APOE—Alzheimer's disease	2.09e-06	9.16e-06	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—ABCA1—Alzheimer's disease	2.08e-06	9.1e-06	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—CAV1—Alzheimer's disease	2.07e-06	9.07e-06	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—MAPK8—Alzheimer's disease	2.07e-06	9.07e-06	CbGpPWpGaD
Ponatinib—LCK—Immune System—IL6—Alzheimer's disease	2.05e-06	8.96e-06	CbGpPWpGaD
Ponatinib—CYP3A5—Metabolism—PTGS2—Alzheimer's disease	2.02e-06	8.83e-06	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—TP53—Alzheimer's disease	2.01e-06	8.78e-06	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—TP53—Alzheimer's disease	2e-06	8.75e-06	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—CASP3—Alzheimer's disease	2e-06	8.74e-06	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—IL6—Alzheimer's disease	1.97e-06	8.62e-06	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—PPARG—Alzheimer's disease	1.93e-06	8.47e-06	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—IL6—Alzheimer's disease	1.93e-06	8.46e-06	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—VEGFA—Alzheimer's disease	1.91e-06	8.38e-06	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism—NOS3—Alzheimer's disease	1.91e-06	8.36e-06	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—INS—Alzheimer's disease	1.9e-06	8.3e-06	CbGpPWpGaD
Ponatinib—LCK—Disease—IL6—Alzheimer's disease	1.89e-06	8.27e-06	CbGpPWpGaD
Ponatinib—LCK—Immune System—AKT1—Alzheimer's disease	1.89e-06	8.27e-06	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—IL6—Alzheimer's disease	1.84e-06	8.03e-06	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—MAPK8—Alzheimer's disease	1.83e-06	8.03e-06	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—IL6—Alzheimer's disease	1.83e-06	8.01e-06	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—PPARG—Alzheimer's disease	1.82e-06	7.98e-06	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—AKT1—Alzheimer's disease	1.82e-06	7.95e-06	CbGpPWpGaD
Ponatinib—SRC—Immune System—IL6—Alzheimer's disease	1.81e-06	7.93e-06	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—PPARGC1A—Alzheimer's disease	1.79e-06	7.85e-06	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—INS—Alzheimer's disease	1.79e-06	7.82e-06	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—HMOX1—Alzheimer's disease	1.78e-06	7.81e-06	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—AKT1—Alzheimer's disease	1.78e-06	7.81e-06	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—TP53—Alzheimer's disease	1.76e-06	7.72e-06	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—TGFB1—Alzheimer's disease	1.76e-06	7.69e-06	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism—PTGS2—Alzheimer's disease	1.75e-06	7.64e-06	CbGpPWpGaD
Ponatinib—LCK—Disease—AKT1—Alzheimer's disease	1.74e-06	7.63e-06	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—VEGFA—Alzheimer's disease	1.69e-06	7.41e-06	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—AKT1—Alzheimer's disease	1.69e-06	7.41e-06	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—AKT1—Alzheimer's disease	1.69e-06	7.39e-06	CbGpPWpGaD
Ponatinib—SRC—Disease—IL6—Alzheimer's disease	1.67e-06	7.32e-06	CbGpPWpGaD
Ponatinib—SRC—Immune System—AKT1—Alzheimer's disease	1.67e-06	7.32e-06	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—NOS3—Alzheimer's disease	1.66e-06	7.28e-06	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—LPL—Alzheimer's disease	1.63e-06	7.14e-06	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—IL6—Alzheimer's disease	1.61e-06	7.07e-06	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—NOS3—Alzheimer's disease	1.57e-06	6.86e-06	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—TGFB1—Alzheimer's disease	1.56e-06	6.81e-06	CbGpPWpGaD
Ponatinib—SRC—Disease—AKT1—Alzheimer's disease	1.54e-06	6.76e-06	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—PTGS2—Alzheimer's disease	1.52e-06	6.66e-06	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—AKT1—Alzheimer's disease	1.49e-06	6.52e-06	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—MTHFR—Alzheimer's disease	1.47e-06	6.43e-06	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—TP53—Alzheimer's disease	1.45e-06	6.33e-06	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—PTGS2—Alzheimer's disease	1.43e-06	6.28e-06	CbGpPWpGaD
Ponatinib—ABCG2—Metabolism—AKT1—Alzheimer's disease	1.41e-06	6.19e-06	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—CALM1—Alzheimer's disease	1.37e-06	6.01e-06	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—APOE—Alzheimer's disease	1.37e-06	5.99e-06	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—CAV1—Alzheimer's disease	1.36e-06	5.93e-06	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—IL6—Alzheimer's disease	1.32e-06	5.79e-06	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—TP53—Alzheimer's disease	1.28e-06	5.6e-06	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—AKT1—Alzheimer's disease	1.22e-06	5.34e-06	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—PPARG—Alzheimer's disease	1.19e-06	5.22e-06	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—IL6—Alzheimer's disease	1.17e-06	5.13e-06	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—INS—Alzheimer's disease	1.17e-06	5.12e-06	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—AKT1—Alzheimer's disease	1.08e-06	4.73e-06	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—NOS3—Alzheimer's disease	1.03e-06	4.49e-06	CbGpPWpGaD
Ponatinib—CYP3A5—Metabolism—AKT1—Alzheimer's disease	1.01e-06	4.44e-06	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—PTGS2—Alzheimer's disease	9.38e-07	4.1e-06	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism—AKT1—Alzheimer's disease	8.78e-07	3.84e-06	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—AKT1—Alzheimer's disease	7.65e-07	3.35e-06	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—AKT1—Alzheimer's disease	7.21e-07	3.15e-06	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—AKT1—Alzheimer's disease	4.71e-07	2.06e-06	CbGpPWpGaD
